| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/24/2008 | US20080176927 difimicin and one or more antioxidants, such as butylated hydroxytoluene; substantially increase shelf life; C. difficile-associated diarrhea |
| 07/24/2008 | US20080176919 Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators |
| 07/24/2008 | US20080176916 A-amino-n-hydroxy-acetamide derivatives |
| 07/24/2008 | US20080176880 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile |
| 07/24/2008 | US20080176871 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors |
| 07/24/2008 | US20080176869 e.g. N-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxamide; viricide in combination with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; AIDS |
| 07/24/2008 | US20080176868 Preparation and use of compounds as protease inhibitors |
| 07/24/2008 | US20080176852 Biguanide and dihydrotriazine derivatives |
| 07/24/2008 | US20080176850 able to inhibit various mutated RTs, including K103N, Y181C and Y188L |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/24/2008 | US20080176841 (amidomethyl-amido)-(carboxy/amido)epoxide derivatives; cathepsin inhibitor; antiinflammatory, anticarcinogenic, antidiabeticagent, antiallergen, autoimmune and neurodegenerative disorders |
| 07/24/2008 | US20080176840 e.g. 4-(4-(6-(N-(2-methoxyethyl)-N-methylamino)pyridin-3-yl)-5-hydroxy-4H-1,2,4-triazol-3-yl)-6-isopropylbenzene-1,3-diol; Heat Shock Protein 90 (HSP90) modulator; antiproliferative, anticarcinogenic, antiinflammatory agent; angiogenesis inhibition, infections |
| 07/24/2008 | US20080176835 Prenyl Transferase Inhibitors |
| 07/24/2008 | US20080176820 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro |
| 07/24/2008 | US20080176818 Sulfoglycolipid Antigens, Their Extraction From Mycobacterium Tuberculosis, and Their Use Against Tuberculosis |
| 07/24/2008 | US20080176813 Carbocyclic nucleosides and process for obtaining such |
| 07/24/2008 | US20080176807 Facially amphiphilic polymers and oligomers and uses thereof |
| 07/24/2008 | US20080176798 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 07/24/2008 | US20080176794 Long lasting fusion peptide inhibitors of viral infection |
| 07/24/2008 | US20080176786 Transgenically produced antithrombin III |
| 07/24/2008 | US20080176270 identifying Francisella tularensis vaccine candidates. It enables identification of novel vaccine candidates and quality assurance for vaccine batches, assessment of protection in vaccinates and identification of the infecting agent in vaccinates. Mice were first vaccinated with Brucella infections |
| 07/24/2008 | US20080176259 Uses of carbamoyl phosphate synthetase 1 (cps 1) and it's fragments for the diagnosis of liver diseases |
| 07/24/2008 | US20080175925 Comprising an antiviral agent (chlorhexidine), an antioxidant agent (reduced glutathione), and an analgesic agent (lidocaine); oral application to mouth tissue; cold sores |
| 07/24/2008 | US20080175918 Chemically cross-linked elastomeric microcapsules |
| 07/24/2008 | US20080175890 Transdermal delivery systems |
| 07/24/2008 | US20080175884 Polymer coatings as carriers for the drug delivery of a methosyaminocarbonyloxy derivative of rapamycin and another drug(s) such as an antiproliferative agent, anticoagulant, etc.; reduces restenosis in vasculature procedures to a level of 0-25%; coronary/periferal stents; grafts ; balloons |
| 07/24/2008 | US20080175869 Mycobacterial sulfation pathway proteins and methods of use thereof |
| 07/24/2008 | US20080175867 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease |
| 07/24/2008 | US20080175866 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms |
| 07/24/2008 | US20080175865 inoculation with a mixture of deactivated forms lactobacillus strains |
| 07/24/2008 | US20080175863 immunogens and vaccines comprising myxovirus proteins having amino acid replacements; genetic engineering |
| 07/24/2008 | US20080175862 Recombinant Flavivirus Vaccines |
| 07/24/2008 | US20080175861 Modified polymerases and attenuated viruses and methods of use thereof |
| 07/24/2008 | US20080175860 comprising leptospira cells, attenuated strains of distemper, adenovirus, parainfluenza virus, parvoviruses and carriers, used for inoculating dogs against pathogens |
| 07/24/2008 | US20080175854 Point mutations; antibodies; fusion proteins |
| 07/24/2008 | US20080175853 Virus-like particles for the induction of autoantibodies |
| 07/24/2008 | US20080175841 Antagonistic Anti-hTNFSF13b Human Antibodies |
| 07/24/2008 | US20080175819 Vector system |
| 07/24/2008 | US20080175811 Method and Composition For Use In Preparation of a Patient For Surgery |
| 07/24/2008 | US20080175796 Delivery of Drug Esters Through an Inhalation Route |
| 07/24/2008 | DE202007008818U1 Zusammensetzung zur Behandlung von Infekten Composition for the treatment of infections |
| 07/24/2008 | DE102007005580A1 Arzneimittel zur Behandlung von Sepsis Drugs for the treatment of sepsis |
| 07/24/2008 | DE102007002924A1 ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung ß-lactam-containing formulations having increased stability in aqueous solution |
| 07/24/2008 | DE102007002717A1 Heterocyclische Indazolderivate Heterocyclic indazole derivatives |
| 07/24/2008 | DE102007002715A1 Triazolderivat Triazole derivative |
| 07/24/2008 | CA2712073A1 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 07/24/2008 | CA2675733A1 Method for glycosylation of flavonoid compounds |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/24/2008 | CA2674589A1 Antiviral nucleoside analogs |
| 07/24/2008 | CA2659858A1 Liposome treatment of viral infections |
| 07/23/2008 | EP1947185A1 HCV NS3/4A encoding nucleic acid |
| 07/23/2008 | EP1947174A1 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 07/23/2008 | EP1947111A1 Novel mucin glycoprotein and use thereof |
| 07/23/2008 | EP1947109A2 Biologically active peptides |
| 07/23/2008 | EP1947106A1 Streptococcus pneumoniae methionyl tRNA synthetase |
| 07/23/2008 | EP1946772A1 Multivalent vaccine composition |
| 07/23/2008 | EP1946771A1 Multivalent vaccine composition |
| 07/23/2008 | EP1946770A1 Uses of DC-sign and DC-signr for inhibiting hepatitis C virus infection |
| 07/23/2008 | EP1946769A2 Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B |
| 07/23/2008 | EP1946768A1 Outer coat protein pa5158 of pseudomonas aeruginosa |
| 07/23/2008 | EP1946748A1 Composition for administration to mammals or humans |
| 07/23/2008 | EP1945665A2 Antibody-based therapeutics with enhanced adcc activity |
| 07/23/2008 | EP1945654A2 Preparation of an antibiotic crystalline fusidic acid |
| 07/23/2008 | EP1945652A1 Macrolones |
| 07/23/2008 | EP1945641A1 Hepatitis c virus inhibitors |
| 07/23/2008 | EP1945623A2 Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same |
| 07/23/2008 | EP1945267A2 Small interfering oligonucleotides comprising arabinose modified nucleotides |
| 07/23/2008 | EP1945254A1 Vaccines and methods to treat canine influenza |
| 07/23/2008 | EP1945237A2 Use of extracts of myrtle and other mediterranean plant species, as antimycotic agent towards yeast and yeast-like microorganisms |
| 07/23/2008 | EP1945219A2 Compound |
| 07/23/2008 | EP1945204A2 V-atpase inhibitors for use in the treatment of septic shock |
| 07/23/2008 | EP1794152B1 Method for manufacturing enantiomeric imidazole compounds |
| 07/23/2008 | EP1744756B1 Use of meloxicam formulations in veterinary medicine |
| 07/23/2008 | EP1684778B1 Herbal extracts of salicornia species, process of preparation thereof, use thereof against tuberculosis |
| 07/23/2008 | EP1663233B1 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
| 07/23/2008 | EP1569933B1 Pyrrolidine and azetidine compounds as ccr5 antagonists |
| 07/23/2008 | EP1565195B1 Anticancer or antiviral composition |
| 07/23/2008 | EP1517692B1 Use of gangliosides for the prevention, inhibition and treatment of sepsis |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1326607B1 Pharmaceutical compositions containing oxapenem-3-carboxilic acids |
| 07/23/2008 | EP1296673B1 Antimicrobial coatings |
| 07/23/2008 | EP1278829B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP0652772B2 Herpesvirus vaccines |
| 07/23/2008 | CN101228262A Novel bacterium belonging to the genus bifidobacterium and utilization of the same |
| 07/23/2008 | CN101228186A TFPI fragments as anti-microbial agents |
| 07/23/2008 | CN101228181A HCV NS3 protease inhibitors |
| 07/23/2008 | CN101228180A Tripeptides as hepatitis C virus inhibitors |
| 07/23/2008 | CN101228169A Macrocyclic inhibitors of hepatitis c virus |
| 07/23/2008 | CN101228120A HIV reverse transcriptase inhibitors |
| 07/23/2008 | CN101228114A Methods of purifying tigecycline |
| 07/23/2008 | CN101228113A Tigecycline and methods of preparing 9-aminominocycline |
| 07/23/2008 | CN101228112A Tigecycline and methods of preparation |
| 07/23/2008 | CN101227919A Peptide-based influenza vaccine formulation |
| 07/23/2008 | CN101225093A Aminoglycoside derivatives |
| 07/23/2008 | CN101225087A Coumarether compound and use of its composition |
| 07/23/2008 | CN101225084A Dihydropyrimidine compound and use thereof in preparation of medicine treating and preventing virus diseases |
| 07/23/2008 | CN101225083A Tetrahydro quinazoline ketone compound and use thereof in preparation of medicine treating and preventing virus diseases |
| 07/23/2008 | CN101224302A Real time individuation poultry egg antibody preparation for anti Hepatitis B or C virus and preparing method and application thereof |
| 07/23/2008 | CN101224301A Application of attenuated live vaccine virus in preparing AIDS and flu treatment medicine |